Exact Sciences · 4 months ago
Bioinformatics Scientist Intern, MRD – Summer 2026
US - CA - San Diego
Internship
Onsite
Intern
$0/yr - $0/yr
Start in 2026 SummerExact Sciences is focused on changing how the world prevents, detects, and guides treatment for cancer. They are seeking a highly motivated summer intern to join their Minimal Residual Disease (MRD) program, where the intern will collaborate with senior bioinformatics scientists to develop methods for improving MRD assays through data science workflows.
BiotechnologyHealth DiagnosticsManufacturingMedical
No H1B
Responsibilities
Analyze genomics data including NGS data
Apply and evaluate machine learning and AI techniques for biomarker discovery
Collect and curate public and internal datasets relevant to MRD research
Program in python and/or R efficiently
Able to use computing resources on AWS effectively
Summarize the work for internal discussion and result sharing
Qualification
Required
Currently pursuing or recently completed Ph.D. in Computer Science, Bioinformatics, Data Science, Mathematics or a related field. Preference giving to candidates with a record of outstanding academic achievement
Strong expertise in machine learning, including familiarity with relevant libraries (e.g., scikit-learn, TensorFlow, PyTorch) and model evaluation techniques
Strong background in statistical analysis
Experience with genomics data preprocessing, feature engineering
Demonstrated ability to perform the essential duties of the position with or without accommodation
Authorization to work in the United States without sponsorship
Preferred
Experience with deep learning frameworks and techniques
Experience handling and analyzing large NGS datasets
Familiar with relational databases and SQL
Benefits
Paid time off (including days for vacation, holidays, volunteering, and personal time)
Paid leave for parents and caregivers
A retirement savings plan
Wellness support
Health benefits including medical, prescription drug, dental, and vision coverage
Company
Exact Sciences
Exact Sciences offers a portfolio of cancer screening and diagnostic tests that span from early detection to treatment monitoring.
Founded in 1995
5001-10000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.75B2025-06-20Acquired
2024-04-11Post Ipo Debt· $620.7M
2023-02-23Post Ipo Debt· $500M
Leadership Team
Kevin Conroy
Chairman & CEO
Aaron Bloomer
Executive Vice President, CFO
Recent News
2026-02-03
Company data provided by crunchbase